| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4222236 | Clinical Imaging | 2009 | 6 Pages |
Abstract
PurposeThe aim of this study was to address the efficacy of 2-[F-18]-Fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) in the staging of non-small cell lung cancer (NSCLC) and in prognostic prediction in patients with NSCLC.MethodsForty-four patients (26 males, 18 females) were analyzed.ResultsAccurate staging was obtained by addition of FDG-PET. Multivariate analysis indicated that the standardized uptake value of the primary tumor was the most significant prognostic factor for disease-free survival (P=.0073).ConclusionFDG-PET is useful for the diagnosis of NSCLC and for prognostic prediction in patients with NSCLC.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Koichiro Abe, Shingo Baba, Koichiro Kaneko, Takuro Isoda, Hidetake Yabuuchi, Masayuki Sasaki, Shuji Sakai, Ichiro Yoshino, Hiroshi Honda,